Search
for
Sort by
Research 631–660 of 1000+
- Safety and Clinical Efficacy of KūlarisTM, an Herbal Supplement for Mild to Severe Acne Vulgaris – A 12-Week Randomized, Double Blind, Placebo-Controlled Study
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Chemoprevention of smoke-induced alopecia in mice by oral administration of l-cystine and vitamin B6
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Testosterone Therapy in Premenopausal Women
- Geriatric Dermatologic Therapy
- Vaping Culture and Cutaneous Health: A Trend with Skin-Deep Consequences
- Polycystic Ovary Syndrome in Adolescents
- Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
- Exploring Herbal Alternatives to Pharmaceutical Treatments for Polycystic Ovary Syndrome
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- The cutaneous serotoninergic/melatoninergic system: securing a place under the sun
- Mesenchymal Stromal Cell Secretome: Influencing Therapeutic Potential by Cellular Pre-conditioning
- A Phase I Study of Topical Tempol for the Prevention of Alopecia Induced by Whole Brain Radiotherapy
- Chronic inflammatory diseases are stimulated by current lifestyle: how diet, stress levels and medication prevent our body from recovering
- Clinical and biological impact of the exposome on the skin
- Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Platelet-derived growth factor signaling modulates adult hair follicle dermal stem cell maintenance and self-renewal
- Parkinson's disease and skin
- Prescribing testosterone and DHEA: The role of androgens in women
- Hormonal therapies for acne
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Spironolactone and XPB: An Old Drug with a New Molecular Target
- Skin diseases in consequence of endocrine alterations
- Dermatologic Reactions to Targeted Therapy
- Exploring the Multifaceted Impact of Acne on Quality of Life and Well-Being
- Clinico-investigative profile of patients of hirsutism in a tertiary level institution